For: | Cuesta-Sancho S, Márquez-Coello M, Illanes-Álvarez F, Márquez-Ruiz D, Arizcorreta A, Galán-Sánchez F, Montiel N, Rodriguez-Iglesias M, Girón-González JA. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response. World J Hepatol 2022; 14(1): 62-79 [PMID: 35126840 DOI: 10.4254/wjh.v14.i1.62] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/62.htm |
Number | Citing Articles |
1 |
Mohamed Shengir, Wesal Elgretli, Felice Cinque, Agnihotram V. Ramanakumar, Rosa Lombardi, Annalisa Cespiati, Anna Ludovica Fracanzani, Luz Ballesteros, Marc Deschenes, Philip Wong, Tianyan Chen, Giada Sebastiani. Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals. Clinics and Research in Hepatology and Gastroenterology 2025; 49(7): 102639 doi: 10.1016/j.clinre.2025.102639
|
2 |
Raffaella Origa. Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending. Pathogens 2023; 12(5): 683 doi: 10.3390/pathogens12050683
|
3 |
Ana-Maria Muñoz-Restrepo, Maria-Cristina Navas, Jimmy Daza, Marcos Girala, Ezequiel Ridruejo, Guido Gerken, Andreas Teufel. Prevention in Hepatology. Journal of Personalized Medicine 2024; 14(2): 132 doi: 10.3390/jpm14020132
|
4 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
5 |
Saba Zafar, Farhat Jabeen, Aiman Sajjad. The Microbiome and Cancer. 2024; : 113 doi: 10.1007/978-981-97-6948-3_5
|